Medical Condition News

RSS

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.

8 Oct 2020

Using mRNA therapies or CRISPR gene editing to treat cystic fibrosis

The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible are reviewed in the peer-reviewed journal Human Gene Therapy.

8 Oct 2020

Laser irradiation shows promise as a new treatment modality for osteoporosis

Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.

8 Oct 2020

Multi-faceted approach required to improve cardiovascular health of LGBTQ population

More than half (56%) of LGBTQ adults and 70% of those who are transgender or gender non-conforming report experiencing some form of discrimination, including the use of harsh or abusive language, from a health care professional.

8 Oct 2020

New computer program detects neurodegeneration biomarkers through magnetic resonance imaging

Magnetic resonance imaging is the most sensitive and reliable technique for diagnosing and monitoring neurodegenerative diseases.

8 Oct 2020

Impaired blood flow to brain regions linked with tau buildup in Alzheimer’s disease

In Alzheimer’s disease, impaired blood flow to brain regions coincides with tau protein buildup. This relationship strengthens as cognition declines, according to new research published in JNeurosci.

8 Oct 2020

New lab-on-a-chip can help study tumor heterogeneity, improve cancer therapies

Electrical engineers, computer scientists and biomedical engineers at the University of California, Irvine have created a new lab-on-a-chip that can help study tumor heterogeneity to reduce resistance to cancer therapies.

8 Oct 2020

Researcher receives NIH award to explore effect of women's hormones on postpartum opioid relapse

When most people think of opioid addiction, they typically do not think of pregnant women. Unfortunately, however, the prevalence of opioid addiction during pregnancy has increased nearly 500% during the past 15 years.

8 Oct 2020

Study shows flash glucose monitors help youth with type1 diabetes

A world-first Otago study has revealed flash glucose monitors help youth with type 1 diabetes better monitor their blood sugar levels, however it does not improve glucose control.

8 Oct 2020

Paying oncology practices to prescribe evidence-based drugs can improve quality of cancer care

A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers report in a new study published online in the Journal of Clinical Oncology.

8 Oct 2020

Pre-existing conditions can increase patient's risk of dying from COVID-19

A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from the virus.

8 Oct 2020

Simple sugar in human breast milk can promote myelin repair in multiple sclerosis patients

N-acetylglucosamine, a simple sugar found in human breast milk and sold as an over-the-counter dietary supplement in the United States, promotes myelin repair in mouse models and correlates with myelination levels in multiple sclerosis patients according to a new University of California, Irvine-led study.

8 Oct 2020

Study: Thymoquinone selectively kills prostate cancer cells at advanced stages

The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.

8 Oct 2020

Anosmia and ageusia may be useful as COVID-19 surveillance case definitions

A recent study published on the preprint server medRxiv in October 2020 reports the utility of alterations in taste and smell to monitor the prevalence of COVID-19 among contacts and in a community that lacks unlimited testing resources.

7 Oct 2020

Study identifies the exact neurons that are most affected by epilepsy

Epilepsy is one of the most common neurological diseases. It is caused by a malfunction in brain cells and is usually treated with medicines that control or counteract the seizures.

7 Oct 2020

New approach can help paramedics better identify patients at high risk for adverse cardiac events

Is this person with chest pain having a heart attack? That's a question EMTs frequently confront when responding to 911 calls.

7 Oct 2020

Study reveals major deficits in addressing asylum seekers’ mental health needs

A new study of asylum seekers in Germany suggests that, among those with symptoms of depression, anxiety, or posttraumatic stress disorder (PTSD), few receive a diagnosis from the health care system, and of those diagnosed, many do not receive treatment.

7 Oct 2020

Global social media challenge kicks off to get the world moving on mental health

A global social media challenge to get the world moving on mental health is launched today with a call for a massive scale-up in investment in mental health.

7 Oct 2020

Robotic exoskeleton improves lives of people with limited or no hand mobility

The Engineering Design and Technological Development Group (DIDET), from the University of Alicante ArtefactosLAB, has once again taken a step forward in terms of social innovation with the design of a new handheld robotic exoskeleton.

7 Oct 2020

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

A recent report published in Science Translational Medicine by MUSC Hollings Cancer Center investigator Sophie Paczesny, M.D., Ph.D., sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD), a life-threatening condition that can arise after hematopoietic stem cell transplantation (HSCT) for treatment of liquid cancers such as leukemia.

7 Oct 2020

Medical Condition News

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Using mRNA therapies or CRISPR gene editing to treat cystic fibrosis

Laser irradiation shows promise as a new treatment modality for osteoporosis

Multi-faceted approach required to improve cardiovascular health of LGBTQ population

New computer program detects neurodegeneration biomarkers through magnetic resonance imaging

Impaired blood flow to brain regions linked with tau buildup in Alzheimer’s disease

New lab-on-a-chip can help study tumor heterogeneity, improve cancer therapies

Researcher receives NIH award to explore effect of women's hormones on postpartum opioid relapse

Study shows flash glucose monitors help youth with type1 diabetes

Paying oncology practices to prescribe evidence-based drugs can improve quality of cancer care

Pre-existing conditions can increase patient's risk of dying from COVID-19

Simple sugar in human breast milk can promote myelin repair in multiple sclerosis patients

Study: Thymoquinone selectively kills prostate cancer cells at advanced stages

Anosmia and ageusia may be useful as COVID-19 surveillance case definitions

Study identifies the exact neurons that are most affected by epilepsy

New approach can help paramedics better identify patients at high risk for adverse cardiac events

Study reveals major deficits in addressing asylum seekers’ mental health needs

Global social media challenge kicks off to get the world moving on mental health

Robotic exoskeleton improves lives of people with limited or no hand mobility

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News